The Yin and Yang of cancer genes.
Alternative splicing
Isoform
Mutation
Oncogene
Post-translational modification
Tumor suppressor gene
Journal
Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761
Informations de publication
Date de publication:
01 Jul 2019
01 Jul 2019
Historique:
received:
23
01
2019
revised:
21
03
2019
accepted:
08
04
2019
pubmed:
14
4
2019
medline:
19
6
2019
entrez:
14
4
2019
Statut:
ppublish
Résumé
Cancer is caused by malfunctioning of genes that normally regulate cardinal processes including various nuclear functions, cell division and survival, cell surface to nucleus signaling cascades, etc. Cancer associated genes are often classified as oncogenes (OCGs) or tumor suppressor genes (TSGs) depending on whether they promote or suppress tumorigenesis, respectively. Such strict classification of cancer genes may however be an over-simplification. Several studies have highlighted a dual role for cancer genes, often impacting the same facet of tumorigenesis. Knowledge of a possible dichotomy of a cancer gene (particularly an OCG) is imperative when evaluating its possible utility as a therapeutic target. Though previous studies have extensively evaluated specific examples of cancer genes exhibiting a dual nature, efforts to unravel the molecular basis for such contrasting functions have been fewer. The current review is an attempt to delineate molecular events underlying the functional dichotomy of cancer genes at the DNA (mutations, gene fusions, etc.), RNA (alternative splicing, regulation through non-coding RNAs, etc.) and protein (isoforms, mis-localisation, post-translational modifications, proteolytic cleavage, etc.) levels.
Identifiants
pubmed: 30980945
pii: S0378-1119(19)30376-2
doi: 10.1016/j.gene.2019.04.025
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
121-133Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.